Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Chailease (5871.TW)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (NT$) Price Target (NT$) Rating
2022-02-28NaN251.24Neutral
2022-06-15217.20267.542Buy
2022-09-28174.05243.569Buy
2022-11-10161.58234.939Buy
2023-01-16221.99256.035Buy
2023-05-15200.42266.046Buy
2023-08-28177.53248.44Buy
2023-11-09174.10237.681Buy
2024-05-06169.21139.87Sell
2024-05-13153.56138.896Sell
2024-08-28144.16127.78Sell
2024-11-12130.50125.00Sell
2025-01-31115.50-No Rating
2025-02-03120.00125.00Sell
2025-02-26125.50110.00Sell
2025-05-14125.00106.00Sell

Disclosures

  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.